Original filing text · Part I

Item 3 — Quantitative and Qualitative Disclosures About Market Risk

West Pharmaceutical Services, Inc. · 10-Q · Q2 FY2026 · Period ended Jun 30, 2026

This is the extracted source text from the SEC filing. Formatting may differ from the original document.

There have been no material changes in our exposure to market risk or the information provided in Part II, Item 7A of our 2025 Annual Report. 42 Table of Contents